Your browser doesn't support javascript.
loading
Defining the versican interactome in lung health and disease.
Tang, Fengying; Brune, Jourdan E; Chang, Mary Y; Reeves, Stephen R; Altemeier, William A; Frevert, Charles W.
Afiliación
  • Tang F; Center for Lung Biology, The University of Washington at South Lake Union, Seattle, Washington.
  • Brune JE; Department of Comparative Medicine, University of Washington, Seattle, Washington.
  • Chang MY; Center for Lung Biology, The University of Washington at South Lake Union, Seattle, Washington.
  • Reeves SR; Department of Comparative Medicine, University of Washington, Seattle, Washington.
  • Altemeier WA; Center for Lung Biology, The University of Washington at South Lake Union, Seattle, Washington.
  • Frevert CW; Department of Comparative Medicine, University of Washington, Seattle, Washington.
Am J Physiol Cell Physiol ; 323(2): C249-C276, 2022 08 01.
Article en En | MEDLINE | ID: mdl-35649251
ABSTRACT
The extracellular matrix (ECM) imparts critical mechanical and biochemical information to cells in the lungs. Proteoglycans are essential constituents of the ECM and play a crucial role in controlling numerous biological processes, including regulating cellular phenotype and function. Versican, a chondroitin sulfate proteoglycan required for embryonic development, is almost absent from mature, healthy lungs and is reexpressed and accumulates in acute and chronic lung disease. Studies using genetically engineered mice show that the versican-enriched matrix can be pro- or anti-inflammatory depending on the cellular source or disease process studied. The mechanisms whereby versican develops a contextual ECM remain largely unknown. The primary goal of this review is to provide an overview of the interaction of versican with its many binding partners, the "versican interactome," and how through these interactions, versican is an integrator of complex extracellular information. Hopefully, the information provided in this review will be used to develop future studies to determine how versican and its binding partners can develop contextual ECMs that control select biological processes. Although this review focuses on versican and the lungs, what is described can be extended to other proteoglycans, tissues, and organs.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Matriz Extracelular / Versicanos Límite: Animals Idioma: En Revista: Am J Physiol Cell Physiol Asunto de la revista: FISIOLOGIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Matriz Extracelular / Versicanos Límite: Animals Idioma: En Revista: Am J Physiol Cell Physiol Asunto de la revista: FISIOLOGIA Año: 2022 Tipo del documento: Article